These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9794670)

  • 1. The rise and fall of levonorgestrel implants: 1992-1996.
    Berenson AB; Wiemann CM; McCombs SL; Somma-Garcia A
    Obstet Gynecol; 1998 Nov; 92(5):790-4. PubMed ID: 9794670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of levonorgestrel implants versus oral contraceptives in adolescence: a case-control study.
    Berenson AB; Wiemann CM
    Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1128-35; discussion 1135-7. PubMed ID: 7726249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
    Sivin I; Campodonico I; Kiriwat O; Holma P; Diaz S; Wan L; Biswas A; Viegas O; el din Abdalla K; Anant MP; Pavez M; Stern J
    Hum Reprod; 1998 Dec; 13(12):3371-8. PubMed ID: 9886517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of levonorgestrel implants on the periodontium.
    Kazerooni T; Ghaffarpasand F; Rastegar N; Kazerooni Y
    Int J Gynaecol Obstet; 2008 Dec; 103(3):255-6. PubMed ID: 18804758
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
    McNicholas C; Swor E; Wan L; Peipert JF
    Am J Obstet Gynecol; 2017 Jun; 216(6):586.e1-586.e6. PubMed ID: 28147241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
    Rosing J; Middeldorp S; Curvers J; Christella M; Thomassen LG; Nicolaes GA; Meijers JC; Bouma BN; Büller HR; Prins MH; Tans G
    Lancet; 1999 Dec; 354(9195):2036-40. PubMed ID: 10636369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant.
    Apter D; Briggs P; Tuppurainen M; Grunert J; Lukkari-Lax E; Rybowski S; Gemzell-Danielsson K
    Fertil Steril; 2016 Jul; 106(1):151-157.e5. PubMed ID: 27016644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urban adolescent females' views on the implant and contraceptive decision-making: a double paradox.
    Kuiper H; Miller S; Martinez E; Loeb L; Darney P
    Fam Plann Perspect; 1997; 29(4):167-72. PubMed ID: 9258648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient satisfaction with a levonorgestrel-releasing contraceptive implant. Reasons for and patterns of removal.
    Haugen MM; Evans CB; Kim MH
    J Reprod Med; 1996 Nov; 41(11):849-54. PubMed ID: 8951137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The levonorgestrel two-rod implant for long-acting contraception: 10 years of clinical experience.
    Wan LS; Stiber A; Lam LY
    Obstet Gynecol; 2003 Jul; 102(1):24-6. PubMed ID: 12850601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adolescent girls' attitudes toward contraceptive subdermal implants.
    Dabrow SM; Merrick CL; Conlon M
    J Adolesc Health; 1995 May; 16(5):360-6. PubMed ID: 7662685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
    Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
    Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with the choice of Norplant by women attending subsidized clinics in the US.
    Frank ML; Poindexter AN; Bateman L
    Adv Contracept; 1993 Jun; 9(2):161-74. PubMed ID: 8237569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability.
    Coukell AJ; Balfour JA
    Drugs; 1998 Jun; 55(6):861-87. PubMed ID: 9617600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal treatment for bleeding irregularities in Norplant implant users.
    Alvarez-Sanchez F; Brache V; Thevenin F; Cochon L; Faundes A
    Am J Obstet Gynecol; 1996 Mar; 174(3):919-22. PubMed ID: 8633669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
    Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
    Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.
    Sivin I
    Drug Saf; 2003; 26(5):303-35. PubMed ID: 12650633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levonorgestrel subdermal implants. Contraception on trial.
    Frank ML; DiMaria C
    Drug Saf; 1997 Dec; 17(6):360-8. PubMed ID: 9429835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of levonorgestrel emergency contraception in Utah: is it more than "plan B"?
    Melton L; Stanford JB; Dewitt MJ
    Perspect Sex Reprod Health; 2012 Mar; 44(1):22-9. PubMed ID: 22405148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.